A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastoma

This publication has 20 references indexed in Scilit:

• Comparison of radiolabeled monoclonal antibody and magnetic resonance imaging in the detection of metastatic neuroblastoma in bone marrow: preliminary results
  Pediatric Radiology, 1989
• Uptake and release of iodine-labelled m-iodobenzylguanidine in a neuroblastoma cell culture system and its importance in neuroblastoma therapy
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1989
• Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.
  Journal of Clinical Pathology, 1989
• Histology of neuroblastoma involving bone marrow: the problem of detecting residual tumour after initiation of chemotherapy
  British Journal of Haematology, 1988
• Metaiodobenzylguanidine (MIBG) labeled with ¹²³I/¹³¹I in neuroblastoma diagnosis and follow‐up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, september 1986
  Medical and Pediatric Oncology, 1987
• MR Imaging in Myelofibrosis
  Journal of Computer Assisted Tomography, 1986
• MR Imaging
  Journal of Computer Assisted Tomography, 1985
• Detection of bone marrow involvement by neuroblastoma: Comparison of two cytological methods
  European Paediatric Haematology and Oncology, 1985
• Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies.
  Journal of Clinical Pathology, 1983
• Nuclear magnetic resonance: in vivo proton chemical shift imaging. Work in progress.
  Radiology, 1983